Cargando…
Safety and Efficacy of Amiodarone in a Patient With COVID-19
There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19). Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis and viral replication. Here, to our knowledge, we report the first case of a patient affected by respiratory failure...
Autores principales: | Castaldo, Nadia, Aimo, Alberto, Castiglione, Vincenzo, Padalino, Cristiano, Emdin, Michele, Tascini, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259916/ https://www.ncbi.nlm.nih.gov/pubmed/32835273 http://dx.doi.org/10.1016/j.jaccas.2020.04.053 |
Ejemplares similares
-
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
por: Aimo, Alberto, et al.
Publicado: (2021) -
Biomarkers for the diagnosis and management of heart failure
por: Castiglione, Vincenzo, et al.
Publicado: (2021) -
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
por: Morfino, Paolo, et al.
Publicado: (2022) -
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
por: Emdin, Michele, et al.
Publicado: (2023) -
Acute Cor Pulmonale in COVID-19-Related ARDS: Improvement With Almitrine Infusion
por: Huette, Pierre, et al.
Publicado: (2020)